Cozaar (losartan) for preventing stroke

Merck will now promote Cozaar (losartan) for preventing stroke.

FDA just approved this new indication for patients with hypertension and left ventricular hypertrophy.

These patients have about twice the risk for stroke compared to patients without left ventricular hypertrophy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote